Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1166 of 1,261
  1. US 6653505

    3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  2. US 6653351

    Adjuvant chemotherapy for anaplastic gliomas

    The Board of Regents of the University of Texas System Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  3. US 6653309

    Inhibitors of IMPDH enzyme technical field of the invention

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  4. US 6653301

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  5. US 6653323

    Aryl aniline &bgr;2 adrenergic receptor agonists

    Theravance, Inc. Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  6. US 6653100

    hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target

    The Regents of the University of California Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  7. US 6653084

    Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  8. US 6652833

    Functionalized active-nucleus complex sensor

    The Regents of the University of California Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  9. US 6653300

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  10. US 6653476

    Thienopyridine derivatives, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  11. US 6653291

    Composition and method for production of transformed cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  12. US 6653452

    Human IRAK-2

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 25, 2003 Β· Expires Nov 20, 2023

    expired
  13. US 6649643

    Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase

    Takeda Chemical Industries Ltd. Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  14. US 6649157

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  15. US 6649654

    Methods for identifying and using IKK inhibitors

    The Regents of the University of California Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  16. US 6649593

    Modulators of SREBP processing

    The Board of Regents of the University of Texas System Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  17. US 6649640

    Isoxazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  18. US 6649411

    Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  19. US 6649631

    Compositions and methods for treating bone deficit conditions

    The Board of Regents of the University of Texas System Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  20. US 6649594

    Compositions for metabolic protection and repair of lips

    The Regents of the University of California Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  21. US 6649364

    Anti-apoptotic compositions and methods using same

    The Regents of the University of California Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  22. US 6649621

    Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms

    United States of America as represented by the Secretary of the Air Force Β· Granted Nov 18, 2003 Β· Expires Nov 13, 2023

    expired
  23. US 6645465

    Annexin proteins and autoantibodies as serum markers for cancer

    MICHIGAN, REGENTS OF THE UNIVERSITY OF, THE Β· Granted Nov 11, 2003 Β· Expires Nov 6, 2023

    expired
  24. US 6644320

    Treatment of hepatitis C using hyperthermia

    First Circle Medical, Inc. Β· Granted Nov 11, 2003 Β· Expires Nov 6, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.